CytRx OverviewLatest common stock for CYTR: $500K.
Get informed when a big investor buys or sells
+ Follow
Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.
CytRx (CYTR) currently reports a common stock of $500K as of March 2025. Use the charts on this page to explore CytRx's common stock history and peer comparisons.
CytRx reported $500K in common stock as of March 2025. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current common stock of $500K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for CytRx, and consider following CYTR for alerts when major investors trade the stock.
CytRx is classified in the Healthcare sector. On common stock, it currently shows $500K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CYTR with unrelated industries.
